Skip to main content

and
  1. Article

    Open Access

    The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target

    Rnd1, a member of Rho GTPases, was found to be downregulated in human malignancies and downregulation of Rnd1 promotes tumor invasion via various mechanisms. However, the role of Rnd1 in hepatocellular carcino...

    Cheng-Dong Qin, De-Ning Ma, Shi-Zhe Zhang, Ning Zhang in Cell Death & Disease (2018)

  2. No Access

    Article

    Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models

    Antiangiogenic therapy, specially sorafenib, has become the standard of care for patients with advanced hepatocellular carcinoma (HCC), however, the improvement in survival time is not satisfactory. Previous s...

    **ao-Dong Zhu, Hui-Chuan Sun, Hua-**ang Xu, Ling-Qun Kong, Zong-Tao Chai in Angiogenesis (2013)